Display options
Cite
Etminan M. Risk of intracranial hypertension with intrauterine levonorgestrel: reply. Ther Adv Drug Saf. 2016;7(1):25-6doi: 10.1177/2042098615621264.
Etminan, M. (2016). Risk of intracranial hypertension with intrauterine levonorgestrel: reply. Therapeutic advances in drug safety, 7(1), 25-6. https://doi.org/10.1177/2042098615621264
Etminan, Mahyar. "Risk of intracranial hypertension with intrauterine levonorgestrel: reply." Therapeutic advances in drug safety vol. 7,1 (2016): 25-6. doi: https://doi.org/10.1177/2042098615621264
Etminan M. Risk of intracranial hypertension with intrauterine levonorgestrel: reply. Ther Adv Drug Saf. 2016 Feb;7(1):25-6. doi: 10.1177/2042098615621264. PMID: 26834961; PMCID: PMC4716392.
Copy Download .nbib Format: NLM
Share it on

Ther Adv Drug Saf. 2016 Feb;7(1):25-6. doi: 10.1177/2042098615621264.

Risk of intracranial hypertension with intrauterine levonorgestrel: reply.

Therapeutic advances in drug safety

Mahyar Etminan

Affiliations

  1. Therapeutic Evaluation Unit, Child & Family Research Institute of British Columbia, Faculty of Medicine, University of British Columbia, A4-198 WS 2, 709-650 West 28 Avenue, Vancouver, BC, Canada.

PMID: 26834961 PMCID: PMC4716392 DOI: 10.1177/2042098615621264

[No abstract available.]

References

  1. Nat Biotechnol. 2012 Feb 08;30(2):137-8 - PubMed
  2. Ther Adv Drug Saf. 2015 Jun;6(3):110-3 - PubMed
  3. J Neurol Sci. 1993 May;116(1):18-28 - PubMed
  4. Contraception. 1990 Apr;41(4):353-62 - PubMed
  5. Arch Neurol. 1990 Mar;47(3):315-20 - PubMed
  6. Pharmacoepidemiol Drug Saf. 2006 May;15(5):291-303 - PubMed

Publication Types